Ankur Varma, MBBS
Full Member
| Research Program:
Cancer Therapeutics
Faculty Rank:
Associate Professor
Campus:
University of Arkansas for Medical Sciences
College:
College of Medicine
Department:
Medicine
|
Cancer Research Interest
- Disease Site Focus: Leukemia/ Lymphoma, Hematologic Malignancies
- Research Focus Area: Treatment, Diagnosis/ Prognosis
- Type of Research: Clinical, Translational
- Research Keywords: AML, ALL, CML, CLL, MDS
- Research Interest Statement: My cancer research focuses on improving treatment outcomes for hematologic cancers, particularly leukemia, lymphoma, and myelodysplastic syndromes (MDS). I am deeply interested in the role of stem cell transplants in treating these conditions, aiming to optimize transplant procedures and reduce complications. Additionally, I explore novel therapeutic approaches to enhance the effectiveness of stem cell transplants and improve long-term survival for patients battling these aggressive blood cancers.
Contact Information
- Email Address: AVarma@uams.edu
- Profiles Research Networking Software: View Profile
Open Clinical Trials
- “MM1YA-S01, “A Randomized Phase II Study Comparing Cytarabine + Daunorubicin(7+3) vs (Daunorubicin and Cytarabine) Liposome, Cytarabine + Daunorubicin +Venetoclax, Azacitidine + Venetoclax, and (Daunorubicin and Cytarabine) Liposome+ Venetoclax in Patients Aged 59 or Younger Who are Considered High-Risk(Adverse) Acute Myeloid Leukemia as Determined by MYELOMATCH; AMyeloMATCH Clinical Trial”” (NCT05554406)
- “MYELOMATCH, Master Screening and Reassessment Protocol (MSRP) for Tier Advancement in the NCI myeloMATCH Clinical Trials” (NCT05564390)
- “Expanded Access Protocol (EAP) for Patients Receiving Lisocabtagene Maraleucel that is Nonconforming for Commercial Release” (NCT04400591)
Recent Publications
- Thalambedu N, Mohan Lal B, Harbaugh B, [et al., including Varma A]. Unveiling Myelodysplastic Syndromes: Exploring Pathogenic Mechanisms and Therapeutic Advances. Cancers. 2025 17(3). PMID: 39941875. PMCID: PMC11816122.
- Pandey T, Inamdar S, Jeffus S, [et al., including Varma A]. Simultaneous Presentation of Relapsed Diffuse Large B-cell Lymphoma and Extrapulmonary Tuberculosis in a Patient With HIV: A Case Report. Cureus. 2025 17(1):e78263. PMID: 40026931. PMCID: PMC11872240.
- Kongtim P, Vittayawacharin P, Zou J, [et al., including Varma A]. ASTCT Consensus Recommendations on Testing and Treatment of Patients with Donor-specific Anti-HLA Antibodies. Transplantation and cellular therapy. 2024 30(12):1139-1154. PMID: 39260570.
- Fugere T, Baltz A, Mukherjee A, [et al., including Varma A]. Immune Effector Cell-Associated HLH-like Syndrome: A Review of the Literature of an Increasingly Recognized Entity. Cancers. 2023 15(21). PMID: 37958323. PMCID: PMC10647774.
- Gannamani V, Varma A, Nathan S, Ustun C. Human herpesvirus 6 (HHV-6) associated permanent hyponatremia in umbilical cord blood transplant recipient. Transplant immunology. 2023 76:101742. PMID: 36372142.
- Baranwal A, Byun J, Ritz E, [et al., including Varma A]. Myeloablative TBI is associated with increased risk of pulmonary GVHD in patients undergoing allogeneic hematopoietic stem cell transplant. Bone marrow transplantation. 2022 57(10):1632-1634. PMID: 35970875.
- Strati P, Varma A, Adkins S, [et al.]. Hematopoietic recovery and immune reconstitution after axicabtagene ciloleucel in patients with large B-cell lymphoma. Haematologica. 2021 106(10):2667-2672. PMID: 32732355. PMCID: PMC8485681.
- Shah MV, Saliba RM, Varma A, [et al.]. Allogeneic stem cell transplant for patients with myeloproliferative neoplasms in blast phase: improving outcomes in the recent era. British journal of haematology. 2021 193(5):1004-1008. PMID: 33821472.
- Yassa G, Varma A, Baptista J, [et al.]. Human Herpesvirus-6 Infection and Calcineurin Inhibitor Pain Syndrome Interaction after Umbilical Cord Blood Transplant. Transplantation and cellular therapy. 2021 27(5):439-440. PMID: 33789834.
- Varma A, Kosuri S, Ustun C, [et al.]. COVID-19 infection in hematopoietic cell transplantation: age, time from transplant and steroids matter. Leukemia. 2020 34(10):2809-2812. PMID: 32801310. PMCID: PMC7427757.
- Varma A, Loya J, Junaid Hussain M, [et al.]. Calcineurin-inhibitor induced pain syndrome after stem cell transplant. Leukemia & lymphoma. 2020 61(9):2230-2233. PMID: 32431182.